Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS.

Kartik Anand,Ethan Burns,Dahlia Sano,Sai Ravi Pingali,Jason R. Westin,Loretta J. Nastoupil,H Lee,Felipe Samaniego,Simrit Parmar,Michael Wang,Misha Hawkins,Sherry Adkins,Luis Fayad,Raphael E Steiner,Ranjit Nair,Sairah Ahmed,Nathan Fowler,Sattva S. Neelapu,Swaminathan Padmanabhan Iyer

Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS.

2019

Kartik Anand
Ethan Burns
Dahlia Sano
Sai Ravi Pingali
Jason R. Westin
Loretta J. Nastoupil
H Lee
Felipe Samaniego
Simrit Parmar
Michael Wang
Misha Hawkins
Sherry Adkins
Luis Fayad
Raphael E Steiner
Ranjit Nair
Sairah Ahmed
Nathan Fowler
Sattva S. Neelapu
Swaminathan Padmanabhan Iyer

2540Background: CAR-T cells targeting CD19 positive B-cells have improved outcomes for relapsed/refractory non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (B-ALL). CAR-T emergent...

Keywords:

Immunology
Pathology
Cart
Chimeric antigen receptor
CD19
Medicine
anti cd19
Cancer research
car t cells
Refractory
Lymphoma
nonrelapse mortality

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations